Article: FDA Battles for Authority Amid Generic-Drug Scandal; HHS Chief Curbs Investigative Role

In July of last year, a senior Food and Drug Administration official and two investigators from the staff of Rep. John D. Dingell (D-Mich.) squared off in a hallway in the FDA's Rockville headquarters.

After a week of searching through the files of the agency's generic-drug division, the two investigators were walking out with documents they thought would help them in their probe of alleged corruption of FDA officials who review drugs for approval. But, according to the staffers, FDA Associate Commissioner Hugh Cannon angrily stopped them and said the documents contained confidential information that they had no authority to remove.

That confrontation, which ended in a shouting match as ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!